» Articles » PMID: 34444971

Predictors of Renal Function Worsening in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Multicenter Observational Study

Abstract

Background: Chronic obstructive pulmonary disease (COPD) patients have multiple comorbidities which may affect renal function. Chronic kidney disease (CKD) is a risk factor for adverse outcomes in COPD patients. The predictors of CKD in COPD are not well investigated.

Methods: A multicenter observational cohort study including patients affected by COPD (GOLD stages 1 and 2) was carried out. Principal endpoints were the incidence of CKD, as defined by an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m, and the rapid decline of eGFR >5 mL/min/1.73 m/year.

Results: We enrolled 707 outpatients. Overall, 157 (22.2%) patients had CKD at baseline. Patients with CKD were older, with higher serum uric acid (UA) levels, and lower FEV. During a mean follow-up of 52.3 ± 30.2 months, 100 patients developed CKD, and 200 patients showed a rapid reduction of eGFR. Multivariable Cox regression analysis displayed that UA (hazard ratio (HR) 1.148, < 0.0001) and diabetes (HR 1.050, < 0.0001) were predictors of incident CKD. The independent predictors of rapidly declining renal function were represented by an increase of 1 mg/dL in UA (odds ratio (OR) 2.158, < 0.0001)), an increase of 10 mL/min/1.73 m in baseline eGFR (OR 1.054, < 0.0001) and the presence of diabetes (OR 1.100, < 0.009).

Conclusions: This study shows that COPD patients have a significant worsening of renal function over time and that UA and diabetes were the two strongest predictors. Optimal management of these risk factors may reduce the incidence of CKD in this population thus probably improving clinical outcome.

Citing Articles

Preserved ratio impaired spirometry, airflow obstruction, and their trajectories in relationship to chronic kidney disease: a prospective cohort study.

Patel I, Zhang J, Chai Y, Qiao Y, Gong H, Xu H Sci Rep. 2025; 15(1):3439.

PMID: 39870785 PMC: 11772821. DOI: 10.1038/s41598-025-86952-6.


Risk factors for renal progression in patients with CKD and coexisting COPD.

Zhu F, Gan W, Liu H, Chen W, Zeng X Int Urol Nephrol. 2024; 57(3):885-895.

PMID: 39400674 DOI: 10.1007/s11255-024-04227-x.


Analysis of chronic kidney disease epidemiology in Kazakhstan using nationwide data for 2014-2020 and forecasting future trends of prevalence and mortality for 2030.

Zhakhina G, Mussina K, Yerdessov S, Gusmanov A, Sakko Y, Kim V Ren Fail. 2024; 46(1):2326312.

PMID: 38482586 PMC: 10946271. DOI: 10.1080/0886022X.2024.2326312.


Association between pulmonary function and rapid kidney function decline: a longitudinal cohort study from CHARLS.

Han S, Xu Y, Wang Y BMJ Open Respir Res. 2024; 11(1).

PMID: 38395458 PMC: 10895224. DOI: 10.1136/bmjresp-2023-002107.


Impact of comorbidities in COPD clinical control criteria. The CLAVE study.

Almagro P, Soler-Cataluna J, Huerta A, Gonzalez-Segura D, Cosio B BMC Pulm Med. 2024; 24(1):6.

PMID: 38166965 PMC: 10759491. DOI: 10.1186/s12890-023-02758-0.


References
1.
Fox C, Larson M, Leip E, Culleton B, Wilson P, Levy D . Predictors of new-onset kidney disease in a community-based population. JAMA. 2004; 291(7):844-50. DOI: 10.1001/jama.291.7.844. View

2.
Kobylecki C, Vedel-Krogh S, Afzal S, Nielsen S, Nordestgaard B . Plasma urate, lung function and chronic obstructive pulmonary disease: a Mendelian randomisation study in 114 979 individuals from the general population. Thorax. 2017; 73(8):748-757. DOI: 10.1136/thoraxjnl-2017-210273. View

3.
Schwartz I, Grupper A, Chernichovski T, Grupper A, Hillel O, Engel A . Hyperuricemia attenuates aortic nitric oxide generation, through inhibition of arginine transport, in rats. J Vasc Res. 2010; 48(3):252-60. DOI: 10.1159/000320356. View

4.
Pelaia C, Vatrella A, Sciacqua A, Terracciano R, Pelaia G . Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives. Expert Rev Respir Med. 2020; 14(5):485-491. DOI: 10.1080/17476348.2020.1732821. View

5.
Barnes P . Mechanisms of development of multimorbidity in the elderly. Eur Respir J. 2015; 45(3):790-806. DOI: 10.1183/09031936.00229714. View